Bengaluru (Karnataka) [India], September 3 (ANI): Karnataka's Commissionerate of Health and Family Welfare Service has issued a standard operating procedure (SOP) for the use of Remdesivir injections in COVID-19 treating facilities.
Bengaluru (Karnataka) [India], Aug 31 (ANI): Biocon Biologics and Mylan on Monday announced the US launch of Semglee™ (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and paediatric patients with type 1 diabetes a
New Delhi [India], Aug 19 (ANI): The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19
Toronto [Canada], August 16 (ANI): A new method has been developed by a team of researchers for injecting healthy cells into vision loss. The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
Bengaluru (Karnataka) [India], August 15 (ANI): The Karnataka government has said that while Remdesivir injections have already been used in government hospitals, the same benefits will be extended to the patients referred through the government to private hospitals.
Toronto [Canada], August 14 (ANI): Researchers have developed a new method of injecting healthy cells into damaged eyes. The technique could point the way toward new treatments with the potential to reverse forms of vision loss that are currently incurable.
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Hyderabad (Telangana) [India], July 18 (ANI): The Hyderabad Police arrested seven persons accused of illegally procuring and selling of COVID-19 antiviral drugs Covifor (Remdesivir) and Cipremi Injections, on Saturday.
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
New Delhi [India], July 9 (ANI): Witnessing the incidence of black marketing and overcharging of the remdesivir injection above MRP, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug